📗 Cite This Artifact
Long-Term Depression (LTD) in Neurodegeneration
Long-Term Depression (LTD) in Neurodegeneration
Introduction
Long Term Depression (Ltd) In Neurodegeneration represents a key pathological mechanism in neurodegenerative diseases. This page explores the molecular and cellular processes involved, their contribution to disease progression, and therapeutic implications. [@malenka2004]
Overview
Long-term depression (LTD) is a type of synaptic plasticity characterized by a persistent weakening of synaptic strength. Unlike [long-term potentiation](/mechanisms/long-term-potentiation) ([LTP](/mechanisms/long-term-potentiation)), which strengthens synapses, LTD reduces the efficiency of synaptic transmission. This process is essential for synaptic homeostasis, learning, and memory refinement. However, dysregulation of LTD has been implicated in the pathogenesis of neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [Amyotrophic Lateral Sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis). [@collingridge2023]
Molecular Mechanisms of LTD Induction
NMDA Receptor-Dependent LTD
...
Long-Term Depression (LTD) in Neurodegeneration
Introduction
Long Term Depression (Ltd) In Neurodegeneration represents a key pathological mechanism in neurodegenerative diseases. This page explores the molecular and cellular processes involved, their contribution to disease progression, and therapeutic implications. [@malenka2004]
Overview
Long-term depression (LTD) is a type of synaptic plasticity characterized by a persistent weakening of synaptic strength. Unlike [long-term potentiation](/mechanisms/long-term-potentiation) ([LTP](/mechanisms/long-term-potentiation)), which strengthens synapses, LTD reduces the efficiency of synaptic transmission. This process is essential for synaptic homeostasis, learning, and memory refinement. However, dysregulation of LTD has been implicated in the pathogenesis of neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and [Amyotrophic Lateral Sclerosis (ALS)](/diseases/amyotrophic-lateral-sclerosis). [@collingridge2023]
Molecular Mechanisms of LTD Induction
NMDA Receptor-Dependent LTD
[NMDA receptor](/entities/nmda-receptor)-dependent LTD is the most extensively studied form of LTD. It requires: [@henley2022]
The calcium influx activates [calcium/calmodulin-dependent protein kinase II (CaMKII)](/proteins/camkii), which paradoxically can trigger LTD under low-frequency stimulation conditions through phosphatase activation. [@wang2024]
Metabotropic Glutamate Receptor (mGluR)-Dependent LTD
[mGluR](/therapeutics/metabotropic-glutamate-receptor-therapeutics)-dependent LTD is induced by activation of group I metabotropic glutamate receptors ([mGluR1](/genes/grm1) and [mGluR5](/genes/grm5)). This form of LTD: [@hu2023]
NMDA vs mGluR LTD Comparison
| Feature | NMDAR-LTD | mGluR-LTD | [@zhang2024]
|---------|-----------|-----------| [@mancini2023]
| Induction | Low-frequency stimulation | Agonist application / paired stimulation | [@kim2024]
| Calcium source | NMDAR | Internal stores + voltage-gated calcium channels | [@citri2008]
| Time course | Slower onset (minutes) | Rapid onset | [@kessels2009]
| Protein synthesis | Not required | Required |
| Key phosphatases | Calcineurin, PP1 | [PP2A](/entities/pp2a), PP1 |
AMPA Receptor Internalization
The primary mechanism of LTD expression involves [AMPA receptor](/proteins/ampa-receptor) internalization:
Role in Synaptic Homeostasis
LTD serves critical homeostatic functions:
- Synaptic scaling: Reduces synaptic strength to prevent overexcitation
- Memory erasure: Enables forgetting of unnecessary information
- Circuit refinement: Eliminates inappropriate synaptic connections during development
- Energy conservation: Reduces metabolic demands of overactive synapses
LTD Dysregulation in Neurodegenerative Diseases
Alzheimer's Disease
In [Alzheimer's disease](/diseases/alzheimers-disease), LTD mechanisms are profoundly disrupted:
- [Amyloid-beta](/proteins/amyloid-beta) ([Aβ](/biomarkers/amyloid-beta-40-abeta-40)) enhances NMDAR-dependent LTD, leading to excessive synaptic weakening
- [Tau protein](/mechanisms/tau-pathology) hyperphosphorylation impairs NMDA receptor trafficking and function
- Excessive calcium dysregulation ([Calcium dysregulation in AD](/mechanisms/calcium-dysregulation-alzheimers)) lowers the threshold for LTD induction
- Synaptic loss correlates with enhanced LTD-like mechanisms
The [amyloid cascade hypothesis](/mechanisms/amyloid-cascade-pathway) now incorporates synaptic plasticity dysregulation including LTD as a key pathogenic mechanism.
Parkinson's Disease
In [Parkinson's disease](/diseases/parkinsons-disease):
- [Alpha-synuclein](/mechanisms/alpha-synuclein) pathology impairs glutamatergic transmission
- [Dopamine](/therapeutics/dopamine-replacement-therapy) depletion alters corticostriatal LTD
- [LRRK2](/genes/lrrk2) mutations affect synaptic plasticity mechanisms
- [PINK1](/genes/pink1) and [Parkin](/genes/prkn) mutations impact mitochondrial function necessary for synaptic plasticity
Amyotrophic Lateral Sclerosis (ALS)
In [ALS](/diseases/amyotrophic-lateral-sclerosis):
- [TDP-43](/biomarkers/tdp-43) pathology disrupts synaptic function
- [FUS](/genes/fus) mutations affect RNA metabolism critical for synaptic proteins
- [SOD1](/genes/sod1) mutations lead to excitotoxicity that modulates LTD
- Cortical hyperexcitability may paradoxically trigger homeostatic LTD mechanisms
Huntington's Disease
In [Huntington's disease](/diseases/huntington-disease):
- [Mutant huntingtin](/biomarkers/mutant-huntingtin-protein) impairs synaptic plasticity gene expression
- [BDNF](/biomarkers/bdnf-brain-derived-neurotrophic-factor) signaling deficits affect LTD induction
- Striatal medium spiny [neurons](/entities/neurons) show altered LTD mechanisms
Therapeutic Implications
Targeting LTD for Neurodegeneration Treatment
Challenges
- LTD and [LTP](/mechanisms/long-term-potentiation)mechanisms/long-term-potentiation) share many molecular mechanisms, making selective targeting difficult
- Normal LTD function is necessary for learning and memory
- Temporal regulation is critical—acute vs. chronic LTD dysregulation may require different approaches
Background
The study of Long Term Depression (Ltd) In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Recent Research Updates (2024-2026)
- Nygren A et al. (2026 Jun 15) [Factors associated with long-term hypnotics use in depression.](https://pubmed.ncbi.nlm.nih.gov/41713603/). J Affect Disord*
- Ng HX et al. (2026 Jun 15) [Brain aging in bipolar disorder using a neuroimaging and machine learning-derived metric: Findings from the ENIGMA BD Working Group.](https://pubmed.ncbi.nlm.nih.gov/41587693/). J Affect Disord*
- Khanna A et al. (2026 May) [The potential for synergistic effect of non-invasive brain stimulation and cognitive behavioural therapy for depressive and cognitive outcomes in major depressive disorder: A scoping review.](https://pubmed.ncbi.nlm.nih.gov/41722328/). Psychiatry Res*
- Xue D et al. (2026 May) [Effects of peer support interventions for family caregivers of persons with dementia: A systematic review and meta-analysis.](https://pubmed.ncbi.nlm.nih.gov/41690252/). Arch Gerontol Geriatr*
- Walter U et al. (2026 Apr 15) [Transcranial sonography of the brainstem raphe: A rapid tool to assess the long-term risk of violent suicidal behavior in patients with major depression.](https://pubmed.ncbi.nlm.nih.gov/41525941/). J Affect Disord*
See Also
- Long-Term Potentiation (LTP) in Neurodegeneration
- Synaptic Plasticity Deficits in Neurodegeneration
- AMPA Receptors in Neurodegenerative Disease
- NMDA Receptor Dysfunction in Neurodegeneration
- Calcium Dysregulation in Neurodegeneration
- [Alzheimer's Disease Pathogenesis](/diseases/alzheimers-disease)
- [Parkinson's Disease Mechanisms](/mechanisms/parkinsons-disease-mechanisms)
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | mechanisms-long-term-depression-neurodegeneration |
| kg_node_id | None |
| entity_type | mechanism |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-ad00ccdf54db |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'mechanisms-long-term-depression-neurodegeneration'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-mechanisms-long-term-depression-neurodegeneration?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Long-Term Depression (LTD) in Neurodegeneration](http://scidex.ai/artifact/wiki-mechanisms-long-term-depression-neurodegeneration)
http://scidex.ai/artifact/wiki-mechanisms-long-term-depression-neurodegeneration